Home/Filings/5/0000899243-23-004791
5//SEC Filing

Riga Thomas J 5

Accession 0000899243-23-004791

CIK 0000831547other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 5:31 PM ET

Size

6.1 KB

Accession

0000899243-23-004791

Insider Transaction Report

Form 5
Period: 2022-12-31
Riga Thomas J
Chief Operating Officer
Transactions
  • Award

    Common Stock, $0.001 par value

    2022-02-14+239,5001,213,340 total
Holdings
  • Common Stock, $0.001 par value

    (indirect: By 401(k))
    14,139
Footnotes (2)
  • [F1]The restricted stock award grant was approved by Spectrum Pharmaceuticals, Inc.'s board of directors on February 14, 2022 with an issuance date of January 14, 2022.
  • [F2]One third of the amount of restricted shares shall vest on each of December 30, 2022, 2023 and 2024, respectively.

Issuer

SPECTRUM PHARMACEUTICALS INC

CIK 0000831547

Entity typeother

Related Parties

1
  • filerCIK 0001726378

Filing Metadata

Form type
5
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:31 PM ET
Size
6.1 KB